Market Research Logo

Global Liquid Biopsy Market Analysis 2016 - Forecast to 2022

Global Liquid Biopsy Market Analysis 2016 - Forecast to 2022

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Liquid Biopsy". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts for 6 years across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, )
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Liquid Biopsy Market by Disease Indication
5.1 Introduction
5.2 Breast Cancer
5.3 Gastrointestinal Cancer
5.4 Lung Cancer
5.5 Colorectal Cancer
5.6 Prostate Cancer
5.7 Leukemia
5.8 Others
6 Liquid Biopsy Market by Biomarker
6.1 Introduction
6.2 Exosomes
6.3 Circulating Tumor DNA (ctDNA)
6.4 Circulating Tumor Cells (CTC)
6.5 Single Gene Analysis (PCR Microarrays)
6.6 Multi - gene - parallel Analysis (NGS)
7 Liquid Biopsy Market by Sample Type
7.1 Introduction
7.2 Urine Sample based
7.3 Blood Sample based
7.4 Other Bio Fluids Based
7.4.1 Saliva
7.4.2 Tissue fluids
8 Liquid Biopsy Market by Application
8.1 Introduction
8.2 Molecular Health Monitoring
8.3 Therapy Selection for Metastatic Breast Cancer (MBS)
8.4 Therapy Selection for Other Metastatic Cancer
10 Geographical Segmentation
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 RoW
10.4.1 Latin America
10.4.2 Middle East
10.4.3 Africa
10.4.4 Others
11 Vendor Landscaping
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiles
12.1 Internap Corporation
12.1.1 Business Overview
12.1.2 SWOT Analysis
12.1.3 Financial Overview
12.1.4 Strategy
12.1.5 Key Activities
12.2 CDN Networks
12.3 Tata Communications
12.4 Level 3 Communications
12.5 Google Inc.
12.6 Limelight Networks, Inc.
12.7 Highwinds Network Group, Inc.
12.8 Akamai Technologies, Inc.
12.9 Verizon Communications, Inc.
12.10 Amazon Web Services, Inc.
12.11 CloudFlare, Inc.
12.12 Orange S.A.
12.12 MaxCDN Enterprise
12.14 Ericssion
12.15 AT&T Inc.
13 Appendix
14 Disclaimer
List of Tables
Table 1 Global Liquid Biopsy Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Liquid Biopsy Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 3 Global breast cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Gastrointestinal Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 5 Global Lung Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 6 Global Colorectal Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 7 Global Prostate Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 8 Global Leukemia Market Analysis, by Region, 2013-2022 ($MN)
Table 9 Global Other Disease Indication Market Analysis, by Region, 2013-2022 ($MN)
Table 10 Global Liquid Biopsy Market Analysis, by Biomarker, 2013-2022 ($MN)
Table 11 Global Exosomes Market Analysis, by Region, 2013-2022 ($MN)
Table 12 Global Circulating Tumor DNA (ctDNA) Market Analysis, by Region, 2013-2022 ($MN)
Table 13 Global Circulating Tumor Cells (CTC) Market Analysis, by Region, 2013-2022 ($MN)
Table 14 Global Single Gene Analysis (PCR Microarrays) Market Analysis, by Region, 2013-2022 ($MN)
Table 15 Global Multi - gene - parallel Analysis (NGS) Market Analysis, by Region, 2013-2022 ($MN)
Table 16 Global Liquid Biopsy Market Analysis, by Sample Type, 2013-2022 ($MN)
Table 17 Global Urine Sample based Market Analysis, by Region, 2013-2022 ($MN)
Table 18 Global Blood Sample based Market Analysis, by Region, 2013-2022 ($MN)
Table 19 Global Other Bio Fluids Based Market Analysis, by Region, 2013-2022 ($MN)
Table 20 Global Other Bio Fluids Based Market Analysis, by Type, 2013-2022 ($MN)
Table 21 Global Liquid Biopsy Market Analysis, by Application, 2013-2022 ($MN)
Table 22 Global Molecular Health Monitoring Market Analysis, by Region, 2013-2022 ($MN)
Table 23 Global Therapy Selection for Metastatic Breast Cancer (MBS) Market Analysis, by Region, 2013-2022 ($MN)
Table 24 Global Therapy Selection for Other Metastatic Cancer Market Analysis, by Region, 2013-2022 ($MN)
Table 25 North America Liquid Biopsy Market Analysis, by Country, 2013-2022 ($MN)
Table 26 North America Liquid Biopsy Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 27 North America breast cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 28 North America Gastrointestinal Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 29 North America Lung Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 30 North America Colorectal Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 31 North America Prostate Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 32 North America Leukemia Market Analysis, by Country, 2013-2022 ($MN)
Table 33 North America Other Disease Indication Market Analysis, by Country, 2013-2022 ($MN)
Table 34 North America Liquid Biopsy Market Analysis, by Biomarker, 2013-2022 ($MN)
Table 35 North America Exosomes Market Analysis, by Country, 2013-2022 ($MN)
Table 36 North America Circulating Tumor DNA (ctDNA) Market Analysis, by Country, 2013-2022 ($MN)
Table 37 North America Circulating Tumor Cells (CTC) Market Analysis, by Country, 2013-2022 ($MN)
Table 38 North America Single Gene Analysis (PCR Microarrays) Market Analysis, by Country, 2013-2022 ($MN)
Table 39 North America Multi - gene - parallel Analysis (NGS) Market Analysis, by Country, 2013-2022 ($MN)
Table 40 North America Liquid Biopsy Market Analysis, by Sample Type, 2013-2022 ($MN)
Table 41 North America Urine Sample based Market Analysis, by Country, 2013-2022 ($MN)
Table 42 North America Blood Sample based Market Analysis, by Country, 2013-2022 ($MN)
Table 43 North America Other Bio Fluids Based Market Analysis, by Country, 2013-2022 ($MN)
Table 44 North America Other Bio Fluids Based Market Analysis, by Type, 2013-2022 ($MN)
Table 45 North America Liquid Biopsy Market Analysis, by Application, 2013-2022 ($MN)
Table 46 North America Molecular Health Monitoring Market Analysis, by Country, 2013-2022 ($MN)
Table 47 North America Therapy Selection for Metastatic Breast Cancer (MBS) Market Analysis, by Country, 2013-2022 ($MN)
Table 48 North America Therapy Selection for Other Metastatic Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 49 Europe Liquid Biopsy Market Analysis, by Country, 2013-2022 ($MN)
Table 50 Europe Liquid Biopsy Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 51 Europe breast cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 52 Europe Gastrointestinal Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 53 Europe Lung Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 54 Europe Colorectal Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 55 Europe Prostate Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 56 Europe Leukemia Market Analysis, by Country, 2013-2022 ($MN)
Table 57 Europe Other Disease Indication Market Analysis, by Country, 2013-2022 ($MN)
Table 58 Europe Liquid Biopsy Market Analysis, by Biomarker, 2013-2022 ($MN)
Table 59 Europe Exosomes Market Analysis, by Country, 2013-2022 ($MN)
Table 60 Europe Circulating Tumor DNA (ctDNA) Market Analysis, by Country, 2013-2022 ($MN)
Table 61 Europe Circulating Tumor Cells (CTC) Market Analysis, by Country, 2013-2022 ($MN)
Table 62 Europe Single Gene Analysis (PCR Microarrays) Market Analysis, by Country, 2013-2022 ($MN)
Table 63 Europe Multi - gene - parallel Analysis (NGS) Market Analysis, by Country, 2013-2022 ($MN)
Table 64 Europe Liquid Biopsy Market Analysis, by Sample Type, 2013-2022 ($MN)
Table 65 Europe Urine Sample based Market Analysis, by Country, 2013-2022 ($MN)
Table 66 Europe Blood Sample based Market Analysis, by Country, 2013-2022 ($MN)
Table 67 Europe Other Bio Fluids Based Market Analysis, by Country, 2013-2022 ($MN)
Table 68 Europe Other Bio Fluids Based Market Analysis, by Type, 2013-2022 ($MN)
Table 69 Europe Liquid Biopsy Market Analysis, by Application, 2013-2022 ($MN)
Table 70 Europe Molecular Health Monitoring Market Analysis, by Country, 2013-2022 ($MN)
Table 71 Europe Therapy Selection for Metastatic Breast Cancer (MBS) Market Analysis, by Country, 2013-2022 ($MN)
Table 72 Europe Therapy Selection for Other Metastatic Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 73 Asia Pacific Liquid Biopsy Market Analysis, by Country, 2013-2022 ($MN)
Table 74 Asia Pacific Liquid Biopsy Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 75 Asia Pacific breast cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 76 Asia Pacific Gastrointestinal Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 77 Asia Pacific Lung Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 78 Asia Pacific Colorectal Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 79 Asia Pacific Prostate Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 80 Asia Pacific Leukemia Market Analysis, by Country, 2013-2022 ($MN)
Table 81 Asia Pacific Other Disease Indication Market Analysis, by Country, 2013-2022 ($MN)
Table 82 Asia Pacific Liquid Biopsy Market Analysis, by Biomarker, 2013-2022 ($MN)
Table 83 Asia Pacific Exosomes Market Analysis, by Country, 2013-2022 ($MN)
Table 84 Asia Pacific Circulating Tumor DNA (ctDNA) Market Analysis, by Country, 2013-2022 ($MN)
Table 85 Asia Pacific Circulating Tumor Cells (CTC) Market Analysis, by Country, 2013-2022 ($MN)
Table 86 Asia Pacific Single Gene Analysis (PCR Microarrays) Market Analysis, by Country, 2013-2022 ($MN)
Table 87 Asia Pacific Multi - gene - parallel Analysis (NGS) Market Analysis, by Country, 2013-2022 ($MN)
Table 88 Asia Pacific Liquid Biopsy Market Analysis, by Sample Type, 2013-2022 ($MN)
Table 89 Asia Pacific Urine Sample based Market Analysis, by Country, 2013-2022 ($MN)
Table 90 Asia Pacific Blood Sample based Market Analysis, by Country, 2013-2022 ($MN)
Table 91 Asia Pacific Other Bio Fluids Based Market Analysis, by Country, 2013-2022 ($MN)
Table 92 Asia Pacific Other Bio Fluids Based Market Analysis, by Type, 2013-2022 ($MN)
Table 93 Asia Pacific Liquid Biopsy Market Analysis, by Application, 2013-2022 ($MN)
Table 94 Asia Pacific Molecular Health Monitoring Market Analysis, by Country, 2013-2022 ($MN)
Table 95 Asia Pacific Therapy Selection for Metastatic Breast Cancer (MBS) Market Analysis, by Country, 2013-2022 ($MN)
Table 96 Asia Pacific Therapy Selection for Other Metastatic Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 97 RoW Liquid Biopsy Market Analysis, by Country, 2013-2022 ($MN)
Table 98 RoW Liquid Biopsy Market Analysis, by Disease Indication, 2013-2022 ($MN)
Table 99 RoW breast cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 100 RoW Gastrointestinal Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 101 RoW Lung Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 102 RoW Colorectal Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 103 RoW Prostate Cancer Market Analysis, by Country, 2013-2022 ($MN)
Table 104 RoW Leukemia Market Analysis, by Country, 2013-2022 ($MN)
Table 105 RoW Other Disease Indication Market Analysis, by Country, 2013-2022 ($MN)
Table 106 RoW Liquid Biopsy Market Analysis, by Biomarker, 2013-2022 ($MN)
Table 107 RoW Exosomes Market Analysis, by Country, 2013-2022 ($MN)
Table 108 RoW Circulating Tumor DNA (ctDNA) Market Analysis, by Country, 2013-2022 ($MN)
Table 109 RoW Circulating Tumor Cells (CTC) Market Analysis, by Country, 2013-2022 ($MN)
Table 110 RoW Single Gene Analysis (PCR Microarrays) Market Analysis, by Country, 2013-2022 ($MN)
Table 111 RoW Multi - gene - parallel Analysis (NGS) Market Analysis, by Country, 2013-2022 ($MN)
Table 112 RoW Liquid Biopsy Market Analysis, by Sample Type, 2013-2022 ($MN)
Table 113 RoW Urine Sample based Market Analysis, by Country, 2013-2022 ($MN)
Table 114 RoW Blood Sample based Market Analysis, by Country, 2013-2022 ($MN)
Table 115 RoW Other Bio Fluids Based Market Analysis, by Country, 2013-2022 ($MN)
Table 116 RoW Other Bio Fluids Based Market Analysis, by Type, 2013-2022 ($MN)
Table 117 RoW Liquid Biopsy Market Analysis, by Application, 2013-2022 ($MN)
Table 118 RoW Molecular Health Monitoring Market Analysis, by Country, 2013-2022 ($MN)
Table 119 RoW Therapy Selection for Metastatic Breast Cancer (MBS) Market Analysis, by Country, 2013-2022 ($MN)
Table 120 RoW Therapy Selection for Other Metastatic Cancer Market Analysis, by Country, 2013-2022 ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report